AMGN three-lens brief
Evidence-based stock research on AMGN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Trading at 91% of its 52-week range — near the top of the band.
- Trading at 91% of its 52-week range — near the top of the band.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 11.4pp over 30 days.
- Debt-to-equity of 376% — balance-sheet-heavy.
- Reported earnings on 2026-11-03.
AMGN closed at $468.11 (+0.62%) as of 2026-11-12. Market cap: $253.21B. P/E (trailing) 27.1. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 11.4pp over 30 days.. Concerns: trading at 91% of its 52-week range — near the top of the band.; debt-to-equity of 376% — balance-sheet-heavy.. Last quarter: Revenue $10.37B, net income $3.86B, free cash flow $7.38B.
Why three lenses on AMGN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMGN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AMGN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMGN brief"></iframe>